<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Deletion of a segment of the long arm of chromosome 6 (6q-) is relatively frequent in <z:hpo ids='HP_0005526'>lymphoid leukemias</z:hpo> and malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, but rare in myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The possible clinical consequences of 6q deletions are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We hav approached this problem by looking for relations between loss of 6q bands and clinical as well as hematological parameters in patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We found that survival was significantly shorter and the 6-q-metaphase prevalences significantly higher when 6q23 had been deleted </plain></SENT>
<SENT sid="4" pm="."><plain>No other 6q band showed non-random associations </plain></SENT>
<SENT sid="5" pm="."><plain>A candidate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene may be encoded in 6q23 </plain></SENT>
</text></document>